SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-053526
Filing Date
2024-02-29
Accepted
2024-02-29 16:42:58
Documents
4
Effectiveness Date
2024-02-29

Document Format Files

Seq Description Document Type Size
1 S-8 d774762ds8.htm S-8 31600
2 EX-5.1 d774762dex51.htm EX-5.1 5407
3 EX-23.1 d774762dex231.htm EX-23.1 1521
4 EX-FILING FEES d774762dexfilingfees.htm EX-FILING FEES 20541
  Complete submission text file 0001193125-24-053526.txt   60131
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277531 | Film No.: 24704554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)